Cell Rich Fat Transfer
Cell Rich Fat Transfer (CRFT) protocol is a special harvesting process with a unique cannula, which gently removes small adipose cell clusters that have been loosened inside the body via mechanical dissociation. It is a harvesting and transfer method that yields consistent volume of highly viable adipose derived regenerative cells (ADRC’s). The CRFT method of autologous fat transfer has been shown to be superior to other methods.
Procedure
The Regenerative Cell procedures’ goal is to harness and enhance the body’s natural mechanism for healing. Cell Rich Fat Transfer (CRFT) is performed in-clinic by our board-certified physician and cardiovascular surgeon, Dr. Henry Childers, assisted by our credentialed medical staff. This cutting-edge procedure is normally conducted on an outpatient basis and under local anesthetic. The total procedure normally takes about 2-3 hours, varying based on the patient’s condition and overall health. The goal of regenerative cell treatment is to minimize pain and advance function without the need for invasive surgery.
- Harvesting of regenerative cells: The harvesting of regenerative cells is primarily acquired using in vivo dissociation with a liposuction procedure to obtain adipose tissue.
- Separation of regenerative cells: Through sterile decantation, the Stromal Vascular Fraction (SVF) is separated from the harvested fat cells.
- Isolation of cells: Using multi-filtration methodologies, regenerative cells and other cells are isolated from the SVF.
- Activation of regenerative cells: Once the isolated regenerative cells are acquired it is added to the patient’s Platelet Rich Plasma (PRP) and activated based on medical procedure protocol.
This process, during its duration, is constantly monitored and controlled by our physician. When considering regenerative cell therapy or making a decision to undergo the procedure as an ideal candidate, it is important to discuss your options with Dr. Childers. Devising a comprehensive treatment plan is crucial, as everyone is different and outcomes will vary.
Conditions Treated with Regenerative Cell Therapy
Delaware Integrative Medicine does not offer stem cell therapy as a cure for any condition, disease or injury. No statements or implied treatments on this website have been evaluated or approved by the FDA. This website contains no medical advice. All statements and opinions provided by this website are provided for educational and informational purposes only and we do not diagnose or treat via this website or via telephone.
Delaware Integrative Medicine and its affiliate treatment centers are offering patients funded each research to provide individuals with autologous stem cells and allograft growth factors. The treatment centers provide surgical procedures only and are not involved in the use of manufacture of any investigational drugs. Delaware Integrative Medicine does not claim that any application or potential applications using autologous or allograft stem cells are approved by the FDA or are even effective. We do not claim that these treatments works for any listed or unlisted condition, intended or implied. It is important for potential patients to do their own research based on the options that we present so that one can make an informed decisions. Any decisions to participate in our patient funded experimental protocols is completely voluntary. If you have any concern with any of our products, methods, website or technique and think we may be violating any US Law, please contact us so that we can investigate the matter or concern immediately.